Related Experiment Video
Updated: Mar 16, 2026
11:29
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.7K
Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications
Ans Rombout1, Bruno Verhasselt1, Jan Philippé2
1Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent University, Ghent, Belgium.
European Journal of Haematology
|August 10, 2016
Summary
Lipoprotein lipase (LPL) mRNA expression predicts chronic lymphocytic leukemia (CLL) aggressiveness. While LPL
Area of Science:
- Oncology
- Hematology
- Biochemistry
Background:
- Chronic lymphocytic leukemia (CLL) is a heterogeneous B-cell malignancy.
- Lipoprotein lipase (LPL) mRNA expression correlates with aggressive CLL phenotypes.
- LPL's prognostic value in CLL is established, but its biological role is unclear.
Purpose of the Study:
- To review the prognostic and biological relevance of LPL in CLL.
- To explore LPL's role in CLL pathogenesis beyond lipid metabolism.
Main Methods:
- Literature review of studies on LPL in CLL.
- Analysis of existing data on LPL expression and patient outcomes.
- Discussion of LPL's known functions in lipid metabolism and non-catalytic roles.
Main Results:
- LPL mRNA is strongly expressed in aggressive CLL and absent in indolent forms.
- LPL expression can predict CLL disease evolution at diagnosis.
- Functional data regarding LPL's role in CLL pathogenesis is limited.
Conclusions:
- LPL is a significant prognostic marker for CLL.
- Further research is needed to elucidate LPL's functional implications in CLL pathogenesis.
- Understanding LPL's non-catalytic roles may reveal new therapeutic targets.
